Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03968055 · ClinicalTrials.gov registry record · NA
Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)
A NA study, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03968055: Active NA study, sponsored by Stanford University.
NCT03968055 is a NA study that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03968055, a NA study, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
To determine if increased targeted contact between patients and the care team can improve diabetes outcomes in the 1st year after diagnosis. We will be using the GluVue platform to remotely view continuous glucose monitor (CGM) data.
Interventions
- OTHER Integration with Epic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-03-25 |
| Est. Completion | 2028-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03968055
The ClinicalTrials.gov registry entry for NCT03968055 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Integration with Epic is the first listed.
NCT03968055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03968055 about?
NCT03968055 is a clinical study titled "Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)". To determine if increased targeted contact between patients and the care team can improve diabetes outcomes in the 1st year after diagnosis. We will be using the GluVue platform to remotely view continuous glucose monitor (CGM) data.
What is the current status of trial NCT03968055?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2019-03-25. Estimated completion is 2028-12-30.
What interventions are being tested in trial NCT03968055?
The interventions under investigation include: Integration with Epic (OTHER).
Who is sponsoring clinical trial NCT03968055?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.